DoW Toxic Exposures Translational Research Award
Agency: Defense Health Agency Contracting Activity - DHACA
- 12.420 -- Military Medical Research and Development
Open opportunityLast Updated: May 21, 2026
Important dates
- Closing: November 19, 2026
Award details
- Expected project funding: $6,000,000
- Expected awards: 4
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:HT942526TERPTRA
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Science technology and other research and development
- Category Explanation:Not specified
History
- Posted date: May 21, 2026
- Archive date: December 19, 2026
- Version: 1
Summary
Jump to documentsSummary: The intent of the fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Translational Research Award (TRA) is to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science, or vice versa, in developing and implementing the research plan.
...Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP TRA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising ideas into clinical applications. Partnering should significantly advance the research beyond what would be possible through individual efforts.
Eligibility
Miscellaneous
- Unrestricted
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| HT942526TERPTRA_GG.pdf | FY26 TERP TRA Program Announcement | May 21, 2026 05:53 PM UTC |
Agency contact information
Email: help@eBRAP.org
eBRAP Help Desk
Link to additional information
No additional information is available
